Cargando…

Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis

BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagnew, Mulat, Belachew, Amare, Tiruneh, Moges, Moges, Feleke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567642/
https://www.ncbi.nlm.nih.gov/pubmed/31195988
http://dx.doi.org/10.1186/s12879-019-4125-x
_version_ 1783427122941919232
author Dagnew, Mulat
Belachew, Amare
Tiruneh, Moges
Moges, Feleke
author_facet Dagnew, Mulat
Belachew, Amare
Tiruneh, Moges
Moges, Feleke
author_sort Dagnew, Mulat
collection PubMed
description BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HEV among pregnant women in Africa. METHODS: We searched, Pub Med, Science direct, African online journals and Google scholar electronic data bases and all available references until August 30, 2018. We included cross sectional studies and cohort studies. The search was further limited studies done in African pregnant women. Statistical analysis done by using Stata (version 11) software. The overall pooled prevalence of HEV presented by using the forest plot with 95% CI. The methodological qualities of included studies were assessed using Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instruments. RESULT: The pooled seroprevalence of HEV among pregnant women in Africa was 29.13% (95% CI 14.63–43.63). The highest seroprevalence was 84.3% in Egypt and the lowest 6.6% reported in Gabon. There was highest heterogeneity level where I(2) = 99.7%; P < 0.0001.The observed heterogeneity attributed to geographic location/ region, country, assay method used in each study and year of study published. Moreover, HEV seroprevalence varies between countries and within countries. The HEV infection among African pregnant women seems to have a decreasing trend over time. CONCLUSION: The seroprevalence of HEV among pregnant women in Africa is high. The seroprevalence of HEV among pregnant women differ with geographic location and assay method. Therefore, it is recommended to conduct further research on commercial ELISA kit sensitivity and specificity, molecular tests, incidence, morbidity and mortality and vertical transmission of HEV from mother to infant in Africa. TRIAL REGISTRATION: CRD42018084963. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4125-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6567642
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65676422019-06-27 Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis Dagnew, Mulat Belachew, Amare Tiruneh, Moges Moges, Feleke BMC Infect Dis Research Article BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HEV among pregnant women in Africa. METHODS: We searched, Pub Med, Science direct, African online journals and Google scholar electronic data bases and all available references until August 30, 2018. We included cross sectional studies and cohort studies. The search was further limited studies done in African pregnant women. Statistical analysis done by using Stata (version 11) software. The overall pooled prevalence of HEV presented by using the forest plot with 95% CI. The methodological qualities of included studies were assessed using Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instruments. RESULT: The pooled seroprevalence of HEV among pregnant women in Africa was 29.13% (95% CI 14.63–43.63). The highest seroprevalence was 84.3% in Egypt and the lowest 6.6% reported in Gabon. There was highest heterogeneity level where I(2) = 99.7%; P < 0.0001.The observed heterogeneity attributed to geographic location/ region, country, assay method used in each study and year of study published. Moreover, HEV seroprevalence varies between countries and within countries. The HEV infection among African pregnant women seems to have a decreasing trend over time. CONCLUSION: The seroprevalence of HEV among pregnant women in Africa is high. The seroprevalence of HEV among pregnant women differ with geographic location and assay method. Therefore, it is recommended to conduct further research on commercial ELISA kit sensitivity and specificity, molecular tests, incidence, morbidity and mortality and vertical transmission of HEV from mother to infant in Africa. TRIAL REGISTRATION: CRD42018084963. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4125-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-13 /pmc/articles/PMC6567642/ /pubmed/31195988 http://dx.doi.org/10.1186/s12879-019-4125-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dagnew, Mulat
Belachew, Amare
Tiruneh, Moges
Moges, Feleke
Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title_full Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title_fullStr Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title_full_unstemmed Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title_short Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
title_sort hepatitis e virus infection among pregnant women in africa: systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567642/
https://www.ncbi.nlm.nih.gov/pubmed/31195988
http://dx.doi.org/10.1186/s12879-019-4125-x
work_keys_str_mv AT dagnewmulat hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis
AT belachewamare hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis
AT tirunehmoges hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis
AT mogesfeleke hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis